Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saab

Showing results (151-160 of 2,590) with videos related to

Pageof 259
Sort By:
Alimentary Pharmacology & Therapeutics|September 18, 2014
Editorial: can we afford the new direct-acting anti-virals for treatment of genotype 1 hepatitis C? Authors' replyS Saab, Z M Younossi
Paediatric Drugs|May 6, 2008
Epidemiology and management options for colorectal cancer in childrenRaya Saab, Wayne L Furman
European Journal of Radiology|March 18, 2008
Nephrogenic systemic fibrosis--implications for nephrologistsGeorges Saab, Ali Abu-Alfa
Frontiers in Pain Research (Lausanne, Switzerland)|October 18, 2024
Beyond pain privacy and pain meters: a new vision for pain biomarkersCharles Djordjevic, Carl Y Saab
The American Journal of Medicine|November 1, 1996
Diagnostic features of tuberculous peritonitisS Saab, L S Rickman
Lancet (London, England)|August 26, 1978
Hodgkin's disease presenting at the elbowP V Sacks, G Saab
Die Pharmazie|April 4, 2019
Disintegration time of orally dissolving films: various methodologies and <i>in-vitro/in-vivo</i> correlationM Saab, M M Mehanna
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2004
Liver transplantation in the era of model for end-stage liver diseaseVictor S Wang, Sammy Saab
Journal of Gastrointestinal Oncology|September 3, 2013
Integrating anti-EGFR therapies in metastatic colorectal cancerSigurdis Haraldsdottir, Tanios Bekaii-Saab
AJR. American Journal of Roentgenology|August 24, 2007
Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration?Georges Saab, Ali Abu-Alfa
Pageof 259

Showing results (151-160 of 2,590) with videos related to

Sort By:
Pageof 259
Alimentary Pharmacology & Therapeutics|September 18, 2014
Editorial: can we afford the new direct-acting anti-virals for treatment of genotype 1 hepatitis C? Authors' replyS Saab, Z M Younossi
Paediatric Drugs|May 6, 2008
Epidemiology and management options for colorectal cancer in childrenRaya Saab, Wayne L Furman
European Journal of Radiology|March 18, 2008
Nephrogenic systemic fibrosis--implications for nephrologistsGeorges Saab, Ali Abu-Alfa
Frontiers in Pain Research (Lausanne, Switzerland)|October 18, 2024
Beyond pain privacy and pain meters: a new vision for pain biomarkersCharles Djordjevic, Carl Y Saab
The American Journal of Medicine|November 1, 1996
Diagnostic features of tuberculous peritonitisS Saab, L S Rickman
Lancet (London, England)|August 26, 1978
Hodgkin's disease presenting at the elbowP V Sacks, G Saab
Die Pharmazie|April 4, 2019
Disintegration time of orally dissolving films: various methodologies and <i>in-vitro/in-vivo</i> correlationM Saab, M M Mehanna
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2004
Liver transplantation in the era of model for end-stage liver diseaseVictor S Wang, Sammy Saab
Journal of Gastrointestinal Oncology|September 3, 2013
Integrating anti-EGFR therapies in metastatic colorectal cancerSigurdis Haraldsdottir, Tanios Bekaii-Saab
AJR. American Journal of Roentgenology|August 24, 2007
Will dialysis prevent the development of nephrogenic systemic fibrosis after gadolinium-based contrast administration?Georges Saab, Ali Abu-Alfa
Pageof 259